豪悦护理(605009) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 reached ¥958,485,931.39, representing a year-on-year increase of 31.65%[4] - The total profit for the period was ¥63,384,826.27, showing a significant decrease of 43.96% compared to the same period last year[4] - The net profit attributable to shareholders was ¥54,876,612.91, down 45.36% year-on-year[4] - The basic earnings per share for the quarter was ¥0.35, reflecting a decline of 25.10% compared to the previous year[5] - Net profit for the first three quarters of 2025 was CNY 203.36 million, a decrease of 30.93% compared to CNY 294.45 million in the same period of 2024[20] - Operating profit for the first three quarters of 2025 was CNY 231.21 million, down from CNY 337.03 million in the previous year, representing a decline of 31.39%[20] - The company reported a total comprehensive income of CNY 213.33 million for the first three quarters of 2025, compared to CNY 277.56 million in 2024, reflecting a decrease of 23.19%[21] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY 0.95, down from CNY 1.35 in the same period of 2024, a decline of 29.63%[21] Assets and Liabilities - The total assets increased by 7.69% to ¥5,224,819,236.02 compared to the end of the previous year[5] - Total assets as of September 30, 2025, amounted to ¥5,224,819,236.02, up from ¥4,851,759,098.61 at the end of 2024, representing a growth of approximately 7.7%[17] - Total liabilities increased to ¥1,838,975,764.01 from ¥1,550,622,539.98, indicating a rise of about 18.6%[16] - The company's equity attributable to shareholders reached ¥3,385,843,472.01, compared to ¥3,301,136,558.63 in the previous year, reflecting an increase of approximately 2.5%[17] Cash Flow - Cash flow from operating activities for the year-to-date was ¥65,676,479.00, a decrease of 73.76% compared to the previous year[4] - Cash flow from operating activities for the first three quarters of 2025 was CNY 65.68 million, a significant decrease of 73.74% compared to CNY 250.32 million in 2024[23] - Cash and cash equivalents as of September 30, 2025, were ¥455,184,139.44, a decrease from ¥1,382,527,655.60 at the end of 2024[15] - Cash and cash equivalents at the end of the third quarter of 2025 were CNY 455.18 million, a decrease of 68.32% from CNY 1.44 billion at the end of the third quarter of 2024[23] - The company incurred a net cash outflow from investing activities of CNY 955.07 million in the first three quarters of 2025, compared to a net outflow of CNY 908.53 million in 2024[23] Revenue and Costs - Total operating revenue for the first three quarters of 2025 reached ¥2,718,448,586.25, a significant increase from ¥2,041,141,698.02 in the same period of 2024, representing a growth of approximately 33.2%[19] - Total operating costs for the first three quarters of 2025 were ¥2,503,834,445.03, compared to ¥1,723,158,469.40 in 2024, indicating an increase of about 45.2%[19] - The gross profit margin for the first three quarters of 2025 was approximately 7.9%, down from the previous year's margin due to rising costs[19] - Total revenue from sales of goods and services for the first three quarters of 2025 reached CNY 2.72 billion, an increase of 35.66% from CNY 2.01 billion in the same period of 2024[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,367[12] - Major shareholder Li Zhibiao holds 34.89% of the shares, followed by Zhu Weili with 22.08%[12] Research and Development - Research and development expenses increased by 30.44 million, reflecting higher investment in R&D[10] - Research and development expenses for the first three quarters of 2025 were ¥96,806,336.22, up from ¥74,213,145.26 in 2024, indicating a growth of about 30.5%[19] Other Financial Metrics - The weighted average return on equity decreased to 1.65%, down 46.69% from the previous year[5] - The weighted average return on net assets for the current reporting period was -46.69%[10] - The company reported non-recurring gains of ¥6,480,570.08 for the period, after accounting for tax effects[7] - Total assets impairment loss amounted to 1,386.72 million, mainly due to equipment impairment provisions[10] - The company raised CNY 310 million in borrowings during the first three quarters of 2025, compared to CNY 300 million in the same period of 2024, indicating a slight increase of 3.33%[23] - Other comprehensive income after tax for the first three quarters of 2025 was CNY 9.97 million, a recovery from a loss of CNY 16.89 million in the same period of 2024[20]